One of the world's largest pharmaceutical companies, Merck KGaA (ETR: MRK), has reiterated its commitment to its partnership with the Ugandan government via its non-profit subsidiary Merck Foundation, Pharmafile reported on Tuesday.
The partnership aims to bolster the country's healthcare abilities and treatment access in the region, with a particular emphasis in areas concerning cancer, cardiovascular disease, diabetes and infertility.
The 'Merck more than a mother' project was first launched in 2012.
"Raising awareness about male infertility is very important to change the culture as [it] affects women and men equally and yet women are the one who been solely blamed, discriminated and mistreated in their communities," commented Merck Foundation CEO Dr Rasha Kelej.
"The campaign will address this topic and encourage men to discuss openly their infertility and share the journey of infertility diagnosis and treatment with their wives."
GE HealthCare expands Vivid cardiovascular ultrasound portfolio with three new systems
Daiichi Sankyo data highlight real-world impact of bempedoic acid on cardiovascular risk
Revier Therapeutics closes EUR6m seed financing and launches operations
Tempus announces receipt of FDA clearance for AI pulmonary hypertension detection product
European Commission grants orphan designation for Lundbeck's asedebart
Hanmi Pharm enters exclusive licensing deal with Genentech for obesity therapy HM17321
PTC to acquire BLA-stage ST-920 Fabry disease programme
Olio Labs reveals study demonstrating AI-driven in vivo platform can predict clinical trial outcomes
Mezzion Pharma Co reports positive results from new in vivo study of udenafil
Incyte's Opzelura approved in European Union for moderate atopic dermatitis